Logo image of ASST

ASSET ENTITIES INC-B (ASST) Stock Fundamental Analysis

NASDAQ:ASST - Nasdaq - US04541A2042 - Common Stock - Currency: USD

6.1465  -0.45 (-6.87%)

Fundamental Rating

2

Overall ASST gets a fundamental rating of 2 out of 10. We evaluated ASST against 98 industry peers in the Media industry. While ASST seems to be doing ok healthwise, there are quite some concerns on its profitability. ASST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ASST had negative earnings in the past year.
In the past year ASST has reported a negative cash flow from operations.
In multiple years ASST reported negative net income over the last 5 years.
In multiple years ASST reported negative operating cash flow during the last 5 years.
ASST Yearly Net Income VS EBIT VS OCF VS FCFASST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

ASST's Return On Assets of -134.56% is on the low side compared to the rest of the industry. ASST is outperformed by 91.84% of its industry peers.
ASST has a worse Return On Equity (-148.23%) than 80.61% of its industry peers.
Industry RankSector Rank
ROA -134.56%
ROE -148.23%
ROIC N/A
ROA(3y)-177.91%
ROA(5y)-95.32%
ROE(3y)-273.24%
ROE(5y)-137.03%
ROIC(3y)N/A
ROIC(5y)N/A
ASST Yearly ROA, ROE, ROICASST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

ASST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASST Yearly Profit, Operating, Gross MarginsASST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

ASST does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASST has been increased compared to 1 year ago.
ASST has a worse debt/assets ratio than last year.
ASST Yearly Shares OutstandingASST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ASST Yearly Total Debt VS Total AssetsASST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 128.47 indicates that ASST is not in any danger for bankruptcy at the moment.
ASST has a better Altman-Z score (128.47) than 98.98% of its industry peers.
ASST has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ASST has a Debt to Equity ratio of 0.10. This is in the better half of the industry: ASST outperforms 74.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 128.47
ROIC/WACCN/A
WACC9.1%
ASST Yearly LT Debt VS Equity VS FCFASST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 9.72 indicates that ASST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 9.72, ASST belongs to the top of the industry, outperforming 98.98% of the companies in the same industry.
ASST has a Quick Ratio of 9.72. This indicates that ASST is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ASST (9.72) is better than 98.98% of its industry peers.
Industry RankSector Rank
Current Ratio 9.72
Quick Ratio 9.72
ASST Yearly Current Assets VS Current LiabilitesASST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.64% over the past year.
The Revenue has grown by 99.44% in the past year. This is a very strong growth!
ASST shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.60% yearly.
EPS 1Y (TTM)2.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.22%
Revenue 1Y (TTM)99.44%
Revenue growth 3Y-8.6%
Revenue growth 5YN/A
Sales Q2Q%36.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASST Yearly Revenue VS EstimatesASST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASST. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASST Price Earnings VS Forward Price EarningsASST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASST Per share dataASST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASSET ENTITIES INC-B

NASDAQ:ASST (6/12/2025, 10:48:51 AM)

6.1465

-0.45 (-6.87%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner Change268.42%
Ins Owners10.27%
Ins Owner Change-2.52%
Market Cap96.93M
AnalystsN/A
Price TargetN/A
Short Float %8.96%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 142.65
P/FCF N/A
P/OCF N/A
P/B 21.38
P/tB 24.09
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.04
BVpS0.29
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -134.56%
ROE -148.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-177.91%
ROA(5y)-95.32%
ROE(3y)-273.24%
ROE(5y)-137.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.72
Quick Ratio 9.72
Altman-Z 128.47
F-Score5
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)99.44%
Revenue growth 3Y-8.6%
Revenue growth 5YN/A
Sales Q2Q%36.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.69%
OCF growth 3YN/A
OCF growth 5YN/A